Ohcanbohtosat - Clifton‐Hadley, Laura

Dose specification for hippocampal sparing whole brain radiotherapy (HS WBRT): considerations from the UK HIPPO trial QA programme Dahkki Megias, Daniel, Phillips, Mark, Clifton-Hadley, Laura, Harron, Elizabeth, Eaton, David J, Sanghera, Paul, Whitfield, Gillian

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgki... Dahkki Cutter, David J., Ramroth, Johanna, Diez, Patricia, Buckle, Andy, Ntentas, Georgios, Popova, Bilyana, Clifton-Hadley, Laura, Hoskin, Peter J., Darby, Sarah C., Radford, John, Illidge, Tim

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin’s lymphoma: a comparison with multi-modality reference standard including (18)F-FDG-... Dahkki Latifoltojar, Arash, Punwani, Shonit, Lopes, Andre, Humphries, Paul D., Klusmann, Maria, Menezes, Leon Jonathan, Daw, Stephen, Shankar, Ananth, Neriman, Deena, Fitzke, Heather, Clifton-Hadley, Laura, Smith, Paul, Taylor, Stuart A.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Treatment of classical Hodgkin lymphoma in young adults aged 18–30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRU... Dahkki Townsend, William, Leong, Sarah, Hoskin, Peter, Diez, Patricia, Patrick, Pip, Linch, David, Wong, Wai‐Lup, Kayani, Irfan, Sanghera, Bal, Lopes, Andre, Daw, Stephen, Collins, Graham, Clifton‐Hadley, Laura, Ardeshna, Kirit

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma Dahkki Brown, Nicholas, McBain, Catherine, Nash, Stephen, Hopkins, Kirsten, Sanghera, Paul, Saran, Frank, Phillips, Mark, Dungey, Fiona, Clifton-Hadley, Laura, Wanek, Katharina, Krell, Daniel, Jeffries, Sarah, Khan, Iftekhar, Smith, Paul, Mulholland, Paul

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma Dahkki Illidge, Tim M., Phillips, Elizabeth H., Counsell, Nicholas, Pettengell, Ruth, Johnson, Peter W. M., Culligan, Dominic J., Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, Barrington, Sally F., Radford, John

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial Dahkki Phillips, Elizabeth H., Burton, Catherine, Kirkwood, Amy A., Barrans, Sharon, Lawrie, Anthony, Rule, Simon, Patmore, Russell, Pettengell, Ruth, Ardeshna, Kirit M., Montoto, Silvia, Paneesha, Shankara, Clifton‐Hadley, Laura, Linch, David C., McMillan, Andrew K.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial Dahkki Anderson, Richard A, Remedios, Rachel, Kirkwood, Amy A, Patrick, Pip, Stevens, Linsey, Clifton-Hadley, Laura, Roberts, Tom, Hatton, Chris, Kalakonda, Nagesh, Milligan, Don W, McKay, Pam, Rowntree, Clare, Scott, Fiona M, Johnson, Peter W M

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study Dahkki Barrington, Sally F., Phillips, Elizabeth H., Counsell, Nicholas, Hancock, Barry, Pettengell, Ruth, Johnson, Peter, Townsend, William, Culligan, Dominic, Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, O’Doherty, Michael J., Illidge, Tim, Radford, John

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial Dahkki Brazil, Lucy, Swampillai, Angela L, Mak, Ka Man, Edwards, Darren, Mesiri, Pavlina, Clifton-Hadley, Laura, Shaffer, Richard, Lewis, Joanne, Watts, Colin, Jeffries, Sarah, Gkogkou, Pinelopi, Chalmers, Anthony J, Fersht, Naomi L, Hackshaw, Allan, Short, Susan C

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial Dahkki Camilleri, Marquita, Sive, Jonathan, Wilson, William, Pang, Gavin, Jenner, Richard, Phillips, Elizabeth, Popat, Rakesh, Ramasamy, Karthik, Bygrave, Ceri, Dadaga, Tushhar, Streetly, Matthew, Cavenagh, James, Chapman, Mike, Barrington, Sally, Pike, Lucy, Owen, Roger, Clifton‐Hadley, Laura, Yong, Kwee

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation Dahkki Hough, Rachael, Lopes, Andre, Patrick, Pip, Russell, Nigel, Raj, Kavita, Tholouli, Eleni, A. Snowden, John, Collin, Matthew, El-Mehidi, Nadjet, Lawrie, Anthony, Clifton-Hadley, Laura, Veys, Paul, Craddock, Charles, Mackinnon, Stephen, Cook, Gordon, Shaw, Bronwen, Marks, David

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study Dahkki Das-Gupta, Emma, Thomson, Kirsty J., Bloor, Adrian J. C., Clark, Andrew D., Mackinnon, Stephen, Kayani, Irfan, Clifton-Hadley, Laura, Patrick, Pip, El-Mehidi, Nadjet, Lawrie, Anthony, Kirkwood, Amy A., Russell, Nigel H., Linch, David C., Peggs, Karl S.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: result... Dahkki Marks, David I, Clifton-Hadley, Laura, Copland, Mhairi, Hussain, Jiaull, Menne, Tobias F, McMillan, Andrew, Moorman, Anthony V, Morley, Nicholas, Okasha, Dina, Patel, Bela, Patrick, Pip, Potter, Michael N, Rowntree, Clare J, Kirkwood, Amy A, Fielding, Adele K

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma Dahkki Watts, Colin, Ashkan, Keyoumars, Jenkinson, Michael D., Price, Stephen J., Santarius, Thomas, Matys, Tomasz, Zhang, Ting Ting, Finch, Alina, Collins, Peter, Allinson, Kieren, Jefferies, Sarah J., Scoffings, Daniel J., Zisakis, Athanasios, Phillips, Mark, Wanek, Katharina, Smith, Paul, Clifton-Hadley, Laura, Counsell, Nicholas

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial Dahkki Mitchell, Rachel J., Kirkwood, Amy A., Barretta, Emilio, Clifton-Hadley, Laura, Lawrie, Emma, Lee, SooWah, Leongamornlert, Daniel, Marks, David I., McMillan, Andrew K., Menne, Tobias F., Papaemmanuil, Elli, Patel, Bela, Patrick, Pip, Rowntree, Clare J., Zareian, Nahid, Alapi, Krisztina Zuborne, Moorman, Anthony V., Fielding, Adele K.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study Dahkki Moorman, Anthony V., Barretta, Emilio, Butler, Ellie R., Ward, Eleanor J., Twentyman, Katie, Kirkwood, Amy A., Enshaei, Amir, Schwab, Claire, Creasey, Tom, Leongamornlert, Daniel, Papaemmanuil, Elli, Patrick, Pip, Clifton-Hadley, Laura, Patel, Bela, Menne, Tobias, McMillan, Andrew K., Harrison, Christine J., Rowntree, Clare J., Marks, David I., Fielding, Adele K.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Dahkki Roddie, Claire, Dias, Juliana, O'Reilly, Maeve A., Abbasian, Mahnaz, Cadinanos-Garai, Amaia, Vispute, Ketki, Bosshard-Carter, Leticia, Mitsikakou, Marina, Mehra, Vedika, Roddy, Harriet, Hartley, John A., Spanswick, Victoria, Lowe, Helen, Popova, Bilyana, Clifton-Hadley, Laura, Wheeler, Graham, Olejnik, Joanna, Bloor, Adrian, Irvine, David, Wood, Leigh, Marzolini, Maria A. V., Domning, Sabine, Farzaneh, Farzin, Lowdell, Mark W., Linch, David C., Pule, Martin A., Peggs, Karl S.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature Dahkki Chapman, Michael A., Sive, Jonathan, Ambrose, John, Roddie, Claire, Counsell, Nicholas, Lach, Anna, Abbasian, Mahnaz, Popat, Rakesh, Cavenagh, Jamie D., Oakervee, Heather, Streetly, Matthew J., Schey, Stephen, Koh, Mickey, Willis, Fenella, Virchis, Andres E., Crowe, Josephine, Quinn, Michael F., Cook, Gordon, Crawley, Charles R., Pratt, Guy, Cook, Mark, Braganza, Nivette, Adedayo, Toyin, Smith, Paul, Clifton-Hadley, Laura, Owen, Roger G., Sonneveld, Pieter, Keats, Jonathan J., Herrero, Javier, Yong, Kwee

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, rand... Dahkki Marks, David I, Kirkwood, Amy A, Rowntree, Clare J, Aguiar, Melanie, Bailey, Katharine E, Beaton, Brendan, Cahalin, Paul, Castleton, Anna Z, Clifton-Hadley, Laura, Copland, Mhairi, Goldstone, Anthony H, Kelly, Richard, Lawrie, Emma, Lee, SooWah, McMillan, Andrew K, McMullin, Mary Frances, Menne, Tobias F, Mitchell, Rachel J, Moorman, Anthony V, Patel, Bela, Patrick, Pip, Smith, Paul, Taussig, David, Yallop, Deborah, Alapi, Krisztina Zuborne, Fielding, Adele K

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta